Drug Standards
Sigma Aldrich Fine Chemicals Biosciences Lomustine European Pharmacopoeia (EP) Reference Standard | 13010-47-4 | MFCD00012392 |
Lomustine European Pharmacopoeia (EP) Reference Standard | Mol Wt: 233.7 | 13010-47-4 | MFCD00012392 |
Sigma Aldrich Fine Chemicals Biosciences Lomustine United States Pharmacopeia (USP) Reference Standard | 13010-47-4 | MFCD00012392 | 200MG
Lomustine United States Pharmacopeia (USP) Reference Standard | Mol Wt: 233.7 | 13010-47-4 | MFCD00012392 | 200MG
Sigma Aldrich Fine Chemicals Biosciences Calcium acetate United States Pharmacopeia (USP) Reference Standard | 62-54-4 | MFCD00012448 | 500MG
Calcium acetate United States Pharmacopeia (USP) Reference Standard | Mol Wt: 158.17 | 62-54-4 | MFCD00012448 | 500MG
Medchemexpress LLC AZD-7762 | 860352-01-8 | MFCD12406007 | 10 mM * 1 mL in DMSO
AZD-7762 | Putity: 99.95% | MW: 362.42 | 860352-01-8 | MFCD12406007 | 10 mM * 1 mL in DMSO
U.S. Pharmacopeia Levomedetomidine | 190000-46-5 | MFCD12912677 | 25mg
Levomedetomidine | 190000-46-5 | MFCD12912677 | 25mg
Medchemexpress LLC Labetalol | 36894-69-6 | 99.9% | 1 ML
Labetalol 10 mM in DMSO (1 mL) is a ready-to-use solution form of an α1/β-adrenergic receptor antagonist for in vitro pharmacology and receptor binding studies. It is provided with analytical documentation for research use.
- Ready-to-use 10 mM solution in DMSO.
- Supplied in a 1 mL vial suitable for small-scale assays.
- High purity for biochemical and pharmacological applications.
- Molecular weight 328.41 g/mol and formula C19H24N2O3.
- Includes certificate of analysis and safety data sheet.
- Intended for in vitro receptor binding and pharmacology studies.
Sigma Aldrich Fine Chemicals Biosciences Dacarbazine British Pharmacopoeia (BP) Reference Standard | 4342-03-4 | MFCD00057167 |
Dacarbazine British Pharmacopoeia (BP) Reference Standard | Mol Wt: 182.18 | 4342-03-4 | MFCD00057167 |
Sigma Aldrich Fine Chemicals Biosciences Timolol maleate British Pharmacopoeia (BP) Reference Standard | 26921-17-5 | MFCD00058356 |
Timolol maleate British Pharmacopoeia (BP) Reference Standard | Mol Wt: 432.49 | 26921-17-5 | MFCD00058356 |
Sigma Aldrich Fine Chemicals Biosciences Clomipramine hydrochloride British Pharmacopoeia (BP) Reference Standard | 17321-77-6 | MFCD00069234 |
Clomipramine hydrochloride British Pharmacopoeia (BP) Reference Standard | Mol Wt: 351.31 | 17321-77-6 | MFCD00069234 |
Medchemexpress LLC Nomegestrol acetate | 58652-20-3 | MFCD00941390 | 99.7% | 370.48 g/mol | C23H30O4 | 50 MG
Nomegestrol acetate is an orally active, highly selective progestogen and progesterone receptor full agonist supplied for research use. It is provided as a solid for preclinical and in vitro endocrine and receptor pharmacology studies.
- Orally active, highly selective progestogen.
- Progesterone receptor full agonist useful for receptor pharmacology.
- High purity suitable for analytical and preclinical studies.
- Solid, white to off-white appearance for stable handling and storage.
- Available in multiple sizes for flexible experimental scale.
- Defined storage conditions to maintain compound stability.
Cayman Chemical RnItIdInhydrochlorIde 1g
A histamine H2 receptor antagonist; reverses histamine-induced relaxation of isolated rat uterine horn (pA2 = 6.9) as well as histamine-induced increases in contraction frequency in isolated guinea pig right atrium (pA2 = 7.2); inhibits histamine-and pentagastrin-induced gastric acid secretion in a dose-dependent manner in anesthetized rats from 0.03-3 mg/kg
Sigma Aldrich Fine Chemicals Biosciences Transplatin United States Pharmacopeia (USP) Reference Standard | 14913-33-8 | MFCD00011623 | 25MG
Transplatin United States Pharmacopeia (USP) Reference Standard | Mol Wt: 300.05 | 14913-33-8 | MFCD00011623 | 25MG
Medchemexpress LLC Ibiglustat (succinate) | 1629063-80-4 | 99.7% | 507.57 | 50 MG
Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. It can be utilized for research related to Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease.
- Orally active.
- Brain-penetrant glucosylceramide synthase (GCS) inhibitor.
- Can be used for research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease.
Medchemexpress LLC ARQ 621 | 1095253-39-6 | ≥99.0% | 552.43 | 50 MG
ARQ 621 is an allosteric, potent and selective inhibitor of Eg5, a microtubule-based ATPase motor protein involved in cell division. Anti-tumor activity. ARQ 621 is a kinesin inhibitor. ARQ 621 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. For research use only. We do not sell to patients.
- ARQ 621 is an allosteric, potent and selective inhibitor of Eg5, a microtubule-based ATPase motor protein involved in cell division. It shows anti-tumor activity.
- It is a kinesin inhibitor.
- It is a click chemistry reagent, containing an Alkyne group, and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
Cayman Chemical ImatInIb-d3 500ug
An internal standard for the quantification of imatinib by GC- or LC-MS